Results 221 to 230 of about 25,852 (233)

Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

Cardiovascular Therapeutics, 2009
Steen Husted, J J J Van Giezen
exaly  

Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development

Expert Opinion on Investigational Drugs, 2020
, Dominick J Angiolillo
exaly  

Platelet P2Y12 Receptor Inhibition

American Journal Cardiovascular Drugs, 2010
David Vivas, Dominick J. Angiolillo
openaire   +1 more source

P2Y 12 Receptor Modulates Sepsis-Induced Inflammation

Arteriosclerosis, Thrombosis, and Vascular Biology, 2016
Elisabetta Liverani, Alexander Y Tsygankov, Laurie E Kilpatrick   +2 more
exaly  

Direct P2Y12 Antagonists

2016
openaire   +1 more source

Synergistic action between inhibition of P2Y12 /P2Y1 and P2Y12 /thrombin in ADP- and thrombin-induced human platelet activation

British Journal of Pharmacology, 2004
Christer Mattsson, Sofia Ramstrom, Tomáš L Lindahl   +2 more
exaly  

The role of P2Y12 receptor antagonists in thrombogenesis

2017
openaire   +1 more source

Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties

Drugs, 2013
Nicola Ferri, Alberto Corsini, Stefano Bellosta   +2 more
exaly  

P2Y12 protects platelets from apoptosis via PI3k‐dependent Bak/Bax inactivation

Journal of Thrombosis and Haemostasis, 2013
Shaoqing Zhang
exaly  

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

Journal of Thrombosis and Haemostasis, 2011
Paul C Armstrong, Melissa V Chan, J A Jakubowski   +2 more
exaly